Mereo BioPharma Group plc Quarterly Entity Common Stock, Shares Outstanding from Q4 2018 to Q2 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Mereo BioPharma Group plc quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q4 2018 to Q2 2024.
  • Mereo BioPharma Group plc Entity Common Stock, Shares Outstanding for the quarter ending August 12, 2024 was 769M shares.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 769M Aug 12, 2024 10-Q 2024-08-13
Q1 2024 701M Feb 29, 2024 10-K 2024-03-27
Q4 2022 625M +40M +6.84% Dec 31, 2022 20-F 2023-03-28
Q4 2021 585M +246M +72.6% Dec 31, 2021 20-F 2022-03-31
Q4 2020 339M +241M +246% Dec 31, 2020 20-F 2021-03-31
Q4 2019 98M +26.7M +37.5% Dec 31, 2019 20-F 2020-06-15
Q4 2018 71.2M Dec 31, 2018 20-F/A 2019-05-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.